Growth & Failure cover image

Dr. Aoife Brennan, President & CEO of Synlogic Therapeutics

Growth & Failure

00:00

Synthetic Biology to Bacterial Diseases

Sinlogic uses synthetic biology to treat metabolic diseases. The company has two programs down the clinic, one for an inherited disease called fenal cetonuria. Another is a acquired metabolic disease where patients have elevated oxilate in leafy green fruits and vegetables or nuts and tea.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app